Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 06, 2023 04:00 ET | Source: AKAMPION

TolerogenixX expands Phase II immune-tolerance trial and closes EUR 12 million Series A financing

Ongoing Phase IIb study expands to arm B5-year results of phase I study confirm efficacy and safety of novel immune-tolerance inducing cell therapy in organ transplantationSecond closing of Series A...
June 06, 2017 08:00 ET | Source: Selecta Biosciences

Selecta Biosciences Announces Upcoming Clinical Presentations

WATERTOWN, Mass., June 06, 2017 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ:SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies...